Lymph Nodes Inhibit T-cell Effector Functions Locally by Establishing Acidic Niches
Citations Over Time
Abstract
Abstract Lymph nodes are an essential component of the adaptive immune response where antigen-presenting cells are closely housed with their cognate effector cells. Protection of lymph node resident cells from activated immune cells in such close quarters would need to be robust and reversible. Effector functions of T-cells are profoundly and reversibly inhibited by an acidic microenvironment. The underlying mechanisms of this inhibition are unknown, but may relate to glycolysis, which is obligatory for expression of effector functions. Here, we demonstrate that acidification rapidly and potently inhibits monocarboxylate transporter-dependent lactic acid efflux, which dually inhibits glycolysis by end-product accumulation and by reducing cytoplasmic pH. Based on the robustness of these responses, we propose that acid-evoked T-cell inhibition is physiologically important, and that lymph nodes are a natural site for such modulation. Using multiple imaging techniques, we show that paracortical T-zones of lymph nodes are highly acidic. We further show that T-cells can be activated by dendritic cells at low pH, and their effector functions are restored rapidly upon increasing pH. Thus, we describe a novel physiological mechanism whereby activated T-cells are kept in stasis by acidosis whilst resident in lymph nodes.
Related Papers
- → Lymph Node Recovery From Colorectal Resection Specimens Removed for Adenocarcinoma:Trends Over Time and a Recommendation for a Minimum Number of Lymph Nodes to be Recovered(1996)285 cited
- → Metastases in Small Lymph Nodes From Colon Cancer(1987)283 cited
- → Lymph sacs are not required for the initiation of lymph node formation(2008)63 cited
- → Lymph node density as a surrogate marker for positive lymph nodes(2010)3 cited
- → Supplementary Table S2 from Molecular Evolution Patterns in Metastatic Lymph Nodes Reflect the Differential Treatment Response of Advanced Primary Lung Cancer(2023)